Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
This is a 75% increase over the number of companies inspected in the previous quarter, when four companies received four inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. The Devices and Drugs sectors sectors, along with one other sector, tied for second most common type.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations. Additionally, one company had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Abiomed, Inc. | Devices | 04/13/2023 | Official Action Indicated (OAI) |
Half Moon Mods, LLC | Tobacco | 04/17/2023 | No Action Indicated (NAI) |
Ipswich Shellfish Company, Inc. | Food and Cosmetics | 06/01/2023 | No Action Indicated (NAI) |
Ora, Inc. | Drugs | 06/28/2023 | No Action Indicated (NAI) |
Pier 7, Inc. | Food and Cosmetics | 04/11/2023 | Voluntary Action Indicated (VAI) |
Pigeon Cove Ferments | Food and Cosmetics | 05/08/2023 | No Action Indicated (NAI) |
Seacrest Foods International, Inc. | Food and Cosmetics | 06/20/2023 | No Action Indicated (NAI) |